Fedratinib - NICE Appraisal : MPN Voice are... - MPN Voice

MPN Voice

10,784 members14,980 posts

Fedratinib - NICE Appraisal

AndyT profile image
0 Replies

MPN Voice are putting together a Patient Group Submission for a forthcoming appraisal by NICE, of Fedratinib for the treatment of myelofibrosis patients with an enlarged spleen or other symptoms.

Fedratinib has been available in England on a limited basis for the last couple of years but we’re hoping that the outcome of this appraisal will make it more generally available to MF patients in England who would benefit from it as an alternative to other treatments.

If you are, or were previously, being treated with Fedratinib we would be very grateful for any feedback you can give us on your experience of it. Any information used in our submission will be anonymous.

Please message me if you’re able to help us with this or if you’d like any more information about the submission and what we are looking for.

Many thanks

Andy Tattersall

Written by
AndyT profile image
AndyT
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Sanofi discontinues clinical development of investigational JAK2 agent Fedratinib (SAR302503)

Press release from Sanofi issued 18th November 2013 regarding the decision to halt all clinical...

NICE Final Guidance on Ruxolitinib for the treatment of Polycythaemia Vera

We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has...

MPN Voice needs your feedback to support an application to the Scottish Medicines Consortium (SMC)

We URGENTLY need your help and feedback to support an application to the Scottish Medicines...

MF and Fedratinib

I've had MF for over 30 years. I was rejected for transplant recently because not robust enough. I...

Myelofibrosis and fedratinib

Just needing a bit of a moan. I've had high risk MF now for many years. Last year I was assessed...